Oct 13, 2024, 22:29
Paul Kelly: The role of Space OAR Vue in modifying the risk of rectal side effects
Paul Kelly, Radiation Oncologist at Bon Secours Hospital Cork UPMC, Ireland shared a post by Karen Molan, Senior Clinical Researcher at on X, adding:
“Great to make a contribution to this prostate cancer radiotherapy SBRT clinical trial, the subject of which is the role of Boston Scientific EMEA – Urology Space OAR Vue in modifying the risk of rectal side effects.
Patients are never the barrier to clinical trial recruitment.”
Quoting Karen Molan:
“Trial Activity.
SABRE Trial Achievement
20 Patients recruited.”
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Oct 13, 2024, 22:29
Oct 13, 2024, 22:29
Oct 13, 2024, 22:29
Oct 13, 2024, 22:27
Oct 13, 2024, 18:16
Oct 13, 2024, 18:07
Oct 13, 2024, 17:58
Oct 13, 2024, 17:49